Table 3.

Demographics and clinical characteristics for the entire patient cohort following endovascular AAA repair.

Variable	All (N = 147)	Survival (N = 110)	Death (N = 37)	p-value
Demographic characteristics
Age, years	72.24 $\pm$ 8.59	70.52 $\pm$ 7.80	77.38 $\pm$ 8.90	0.000*
Sex, male	128 (83.07%)	97 (88.18%)	31 (83.78%)	0.490
BMI, kg/$m^2$	24.34 $\pm$ 3.84	24.83 $\pm$ 3.81	22.87 $\pm$ 3.58	0.007*
Medical history and comorbidities
Smoking history	67 (44.26%)	50 (45.45%)	17 (45.95%)	0.959
Hypertension	107 (72.79%)	78 (70.91%)	29 (78.39%)	0.377
Diabetes	26 (17.69%)	18 (16.36%)	8 (21.62%)	0.468
Hyperlipidemia	43 (29.25%)	32 (29.09%)	11 (29.73%)	0.941
COPD	11 (7.48%)	5 (4.55%)	6 (16.21)	0.020*
Coronary artery disease	70 (47.62%)	50 (45.45%)	20 (54.05%)	0.365
Myocardial infarction	33 (22.45%)	26 (23.64%)	7 (18.92%)	0.552
Prior CABG	7 (4.76%)	6 (5.45%)	1 (2.70)	0.497
Prior PCI	25 (17.01%)	21 (19.09%)	4 (10.81%)	0.246
Cerebrovascular accident	25 (17.01%)	16 (14.55%)	9 (24.32)	0.171
Chronic renal impairment	16 (10.88%)	8 (7.27%)	8 (21.62)	0.015*
Clinical features
WBCs ($\times$${\mathrm{10}}^3$/mL)	6.18 (5.35–7.74)	6.09 (5.26–7.55)	6.56 (5.66–8.06)	0.252
Neutrophil count ($\times$${\mathrm{10}}^3$/mL)	3.84 (3.11–5.03)	3.69 (3.08–4.55)	4.78 (3.49–6.15)	0.006*
Lymphocyte count ($\times$${\mathrm{10}}^3$/mL)	1.50 (1.14–2.02)	1.66 (1.19–2.13)	1.22 (1.03–1.62)	0.001*
Monocyte count ($\times$${\mathrm{10}}^3$/mL)	0.49 (0.39–0.57)	0.49 (0.38–0.57)	0.48 (0.40–0.56)	0.975
Red cell distribution width	12.9 (12.5–13.5)	12.8 (12.4–13.4)	13.2 (12.65–14.45)	0.054
Hemoglobin (mg/dL)	129.0 (115.25–141.0)	136.0 (120.0–144.0)	116.0 (98.50–124.50)	0.000*
Platelets (n/µL)	181.0 (146.0–220.0)	186.0 (158.0–231.5)	161.0 (106.5–191.5)	0.003*
NLR	2.58 (1.79–3.70)	2.18 (1.70–3.31)	3.63 (2.72–5.21)	0.000*
PLR	116.07 (85.95–155.45)	113.84 (84.54–157.52)	130.68 (92.33–147.8)	0.444
SII	445.33 (311.03–708.63)	426.21 (305.83–646.41)	597.73 (345.26–786.11)	0.072
SIRI	1.20 (0.77–1.94)	1.06 (0.70–1.74)	1.72 (1.06–2.72)	0.001
HRR	10.08 (8.35–11.20)	10.48 (9.44–11.52)	8.49 (7.28–9.80)	0.000*
Creatinine (mmol/L)	83.0 (77.50–104.0)	80.0 (70.0–99.0)	99.5 (78.0–130.5)	0.001
Albumin (g/L)	39.0 (36.0–41.0)	39.0 (37.0–41.0)	36.0 (34.5–38.5)	0.000*
Aneurysm diameter (mm)	55.0 (50.0–65.0)	55.0 (48.0–60.0)	64.0 (54.0–75.0)	0.001*

* indicates the p-value is less than 0.05.

Data are presented as n (%), mean $\pm$ standard deviation, or median (interquartile range, IQR). BMI, body mass index; COPD, chronic obstructive pulmonary disease; WBCs, white blood cells; CABG, coronary artery bypass grafting; PCI, percutaneous coronary intervention.